Cameron Doerksen

Fadi Chamoun

Kevin Chiang

Benoit Poirier

James McGarragle

Konark Gupta

Sheila Kahyaoglu

Tim James

Elie Salameh

Greg Konrad

Kristine Liwag

Noah Poponak

- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) announced the closing of its acquisition of an intellectual property (IP) portfolio featuring **artificial intelligence, 3D bioprinting, and quantum modeling technologies**.  **[1173382_b77bc9b8473e49608ebba28555cc3835_0]** 
- The transaction for the IP portfolio was valued at **$3.5 million**, comprising **$500,000 in cash** and **$3 million in NeOnc common stock** at a price of **$25 per share**.  **[1173382_b77bc9b8473e49608ebba28555cc3835_0]** 
- This acquisition is expected to significantly fortify NeOnc’s drug discovery engine, enabling the creation of patient-derived 3D brain tumor models and high-throughput screening of therapeutic candidates, which is designed to **de-risk and shorten the preclinical development timeline**.  **[1173382_b77bc9b8473e49608ebba28555cc3835_0]** **[1173382_b77bc9b8473e49608ebba28555cc3835_1]** 
- Concurrent with the acquisition's closing, NeOnc formally welcomed **Dr. Ishwar K. Puri**, Senior Vice President of Research and Innovation at the University of Southern California (USC), to its Board of Directors.  **[1173382_b77bc9b8473e49608ebba28555cc3835_0]** **[1173382_b77bc9b8473e49608ebba28555cc3835_1]**

NeOnc Technologies Closes AI and 3D Bioprinting IP Acquisition, Appoints Dr. Puri to Board

CAE (CAE)